• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Lexenpharm`s Generics Formoterol Fumarate Receives Approval in US

    FDA

    Micro Labs Generic Formoterol Fumarate Receives Approval in US

    FDA

    Viatris Announces Launch of Breyna™ Inhalation Aerosol

    PR NEWSWIRE

    Slayback`s Generic Formoterol Fumarate Receives Approval in the U.S.

    FDA

    Briefs: Lupin and GMM Pfaudler

    INDIANPHARMAPOST

    Aucta`s Generic Formoterol Fumarate Receives Approval in the U.S.

    FDA

    Lupin gets USFDA nod for Formoterol Fumarate inhalation solution

    HEALTH ET

    Lupin`s Generic Formoterol Fumarate Receives Approval in the U.S.

    FDA

    NHS Scotland recommends Chiesi’s Trimbow for asthma

    PHARMAFILE

    Mylan`s Generic Budesonide and Formoterol Fumarate Receives Approval in the U.S.

    FDA

    Astrazeneca`s Biologic Riltrava Aerosphere Receives Approval in Europe

    EMA

    Alembic Pharma`s Generic Formoterol Fumarate Receives Approval in the US

    FDA

    AZ posts first-in-class win for asthma rescue inhaler

    FIERCEPHARMA

    EU for AZ` COPD maintenance therapy

    PHARMATIMES

    European approval for AstraZeneca`s Trixeo Aerospace in moderate to severe COPD

    PHARMAFILE

    New analyses from Breztri Aerosphere Phase III ETHOS trial to be presented

    PRESS RELEASE

    FDA Approvals Roundup: Tecartus, Breztri Aerosphere, Wynzora

    RAPS

    AstraZeneca’s phase III ETHOS trial of triple-combo therapy Breztri Aerosphere

    PHARMABIZ

    Breztri Aerosphere significantly reduced rate of moderate or severe COPD

    PRESS RELEASE

    AstraZeneca’s Bevespi Aerosphere approved in China for patients with COPD

    PRESS RELEASE

    Lupin Ltd`s Generic Arformoterol Tartrate Receives Tentative Approval In US

    FDA

    Teva Pharma`s Generic Budesonide/Formoterol Receives Approval in Europe

    EMA

    Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® for patients with COPD

    BIOSPACE

    FDA rejects AZ’s COPD triplet Breztri

    FIERCE PHARMA

    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    FIERCE PHARMA

    AstraZeneca’s COPD triplet Breztri nabs first nod from Japan

    FIERCE PHARMA

    AZ Symbicort reduces rate of asthma attacks

    PHARMA TIMES

    As AZ`s cancer drugs surge, CEO talks up `next phase`

    FIERCE PHARMA

    US Food and Drug Administration Approves DUAKLIR® PRESSAIR®

    BUSINESSWIRE

    SYMBICORT Brand Expands RCR Partnership in 2019

    PADDOCK TALK

    AstraZeneca AB`s Bevespi Aerosphere (glycopyrronium / formoterol fumarate dihydrate) Receives Approval in Europe

    EMA

    EMA approves Flutiform for children with asthma

    PHARMA TIMES

    AstraZeneca’s respiratory team acknowledges its latest setback, trial flops

    ENDPTS

    Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)

    EMA

    Symbicort (budesonide/formoterol fumarate dihydrate) : AstraZeneca vs. Mylan

    PATENT LITIGATION

    AZ prepares to file COPD triple, taking on rival GSK

    PM LIVE

    AstraZeneca: KRONOS Phase III Trial Met 8 of 9 Primary Endpoints

    MARKETS INSIDER

    FDA Confirms Paragraph IV Patent Challenge of Symbicort 21929 (Budesonide and Formoterol Fumarate Dihydrate ) Metered Inhalation

    FDA

    AZ rival to GSK’s COPD drug Anoro fails head-to-head test

    PMLIVE

    Hit by surprise setback, AZ explains why inhaler beaten by GSK rival

    ENDPTS

    AstraZeneca inhaler lags GSK drug in lung disease trial

    REUTERS

    Chiesi Farmaceutici`s Riarify (beclometasone;formoterol;glycopyrronium bromide) Receives Approval In Europe

    EMA

    Five new medicines backed for EU approval

    PHARMA TIMES

    EMA’s CHMP Recommends Five New Medicines for Approval

    RAPS

    Five medicines recommended for approval, including two orphans

    EMA

    Busy AZ posts Q4 beats, with execs promising skid`s end is near

    FIERCE PHARMA

    AZ`s latest respiratory win could spur Asian Bevespi nods

    FIERCE PHARMA

    Cipla’s Generic Arformoterol Tartrate Receives Tentative Approval In US

    FDA

    Chiesi Farmaceutici`s Trimbow (beclometasone / formoterol / glycopyrronium bromide) Receives Approval In Europe

    EMA

    EU nod for Chiesi’s COPD therapy

    PHARMA TIMES

    Flex Pharma Announces Executive Leadership Transition

    BUSINESSWIRE

    EMA’s CHMP Recommends Approval for Five New Medicines, Four New Biosimilars

    RAPS

    AstraZeneca`s Symbicort Granted Pediatric Exclusivity by FDA

    NASDAQ

    Five pharmas Fall Foul of ABPI Code of Practice

    PHARMATIMES

    GSK files triple combo for COPD in Europe

    PHARMATIMES

    AstraZeneca : Symbicort Improves Lung Function In Pediatric Asthma Patients

    NASDAQ

    Pearl`s Bevespi Aerosphere (Glycopyrrolate;Formoterol Fumarate) approved in US for Chronic Obstructive Pulmonary Disease (COPD)

    FDA

    Merck Canada Recalls Zenhale Aerosol due to the possibility of device malfunction

    HEALTHY CANADIANS

    Novartis Initiates Class III Recall of Foradil Aerolizer (formoterol fumarate inhalation powder) Due to Failed Stability Specification

    FDA

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.